Detalhe da pesquisa
1.
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.
J Oncol Pharm Pract
; 27(4): 907-910, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33108988
2.
Off-label infusion of biosimilar bevacizumab: A provincial experience.
J Oncol Pharm Pract
; 26(7): 1683-1685, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727322
3.
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
Curr Oncol
; 30(4): 3776-3786, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185399